Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms
, , , , , and | Jul 07, 2022
About this article
Article Category: Original article
Published Online: Jul 07, 2022
Page range: 126 - 130
Received: Feb 01, 2022
Accepted: May 01, 2022
DOI: https://doi.org/10.2478/aiht-2022-73-3635
© 2022 Snežana Đorđević, Nataša Perković Vukčević, Marko Antunović, Vesna Kilibarda, Gordana Vuković Ercegović, Jasmina Jović Stošić, and Slavica Vučinić, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Patients with serum olanzapine concentrations above the lethal threshold of 1 mg/L
| Patient | Sex | Age | Ingested dose | Time from ingestion to blood collection | Concentration (mg/L) | PSS |
|---|---|---|---|---|---|---|
| 1 | male | 26 | about 150 mg | 6 h | 3.40 | 2 |
| 2 | female | 26 | 1680 mg | 5 h | 2.44 | 3 |
| unknown | >12 h | 1.75 | 3 | |||
| 3 | female | 59 | 560 mg | 3 h | 1.53* | 4 |
| 4 | male | 43 | unknown | >24 h | 1.18 | 3 |
Serum concentrations of co-ingested drugs (mg/L) during the hospitalisation
| Day | Olanzapine (mg/L) | Clozapine (mg/L) | Norclozapine (mg/L) | Lamotrigine (mg/L) | Midazolam (mg/L) | Zolpidem (mg/L) |
|---|---|---|---|---|---|---|
| 1 | 0.28 | 0.29 | 0.02 | 3.62 | 0.21 | 0.83 |
| 2 | 0.42 | 0.22 | 0.03 | 2.19 | <LOD | 0.19 |
| 3 | 0.59 | 0.49 | <LOD | 2.74 | <LOD | 0.15 |
| 4 | 1.53 | 0.68 | <LOD | 3.5 | <LOD | 0.14 |
| 5 | 0.31 | 0.7 | <LOD | < 1.0 | <LOD | 0.06 |